Ontario Bioscience Innovation Organization Announces a National Call to Companies for Applications for the 2019 Niagara Investment Summit

TORONTO–(BUSINESS WIRE)–#healthscience–The Ontario Bioscience Innovation Organization (OBIO®) is announcing a
national call for applications from health science companies who are
seeking Series A or beyond investments to participate in the OBIO 2019
Niagara Investment Summit on February 20-22, 2019.

The OBIO 2019 Niagara Investment Summit will bring 30 of Canada’s most
promising health science companies to Niagara-on-the-Lake to present to
and meet with global investors. The Summit will feature keynote
presentations and panel discussions from world-leading scientific and
business experts.

“At OBIO’s 2019 Niagara Investment Summit, we will bring our most
innovative Canadian health science companies together with leading
global investors to create opportunities for new and cross-border
investments,” said Gail Garland, President and CEO, OBIO. “With
world-class technologies and a great environment for investment,
Canadian companies present an incredible opportunity for global health
science investors and we are looking forward to bringing the world to
Canada’s doorstep.”

The theme of the 2019 Niagara Investment Summit is “Precision Medicine:
Canada, A Leader in the New Era,” which will highlight three
fast-growing sectors:
(1) AI in Health
(2) New Frontiers in
Medicine
(3) Digital Health and Diagnostics

Companies selected to participate in the 2019 Niagara Investment Summit
will be on a rolling basis and presentation spots are limited.
Interested companies should send an email to Christina Yeh (christinayeh@obio.ca)
and include a non-confidential pitch deck (15 slides maximum),
demonstrating how your company fits within the theme of Precision
Medicine.

Selected companies are responsible for the conference fee of $2,500
which includes:

  • Full registration for one company representative
  • An opportunity to pitch and hold one-on-one meetings with leading
    global investors
  • Attendance at a health science CEO roundtable dinner discussion
  • Two nights’ accommodation
  • Breakfast, lunch and dinner for the duration of the conference

OBIO 2019 Niagara Investment Summit Eligibility

  • Companies based in Canada focused on developing health science
    products or services including but not limited to therapeutics,
    medical devices, diagnostics, or digital health which fit into the
    themes of the 2019 Niagara Investment Summit.
  • Companies based in Canada seeking to raise Series A and beyond
    investment.

About OBIO

The Ontario Bioscience Innovation Organization (OBIO®), a leading
advocate for Canada’s health science industry, is a not-for-profit,
membership-based organization engaged in the development of an
integrated health innovation economy and one that will become a global
leader in providing health technology products and services to the
international marketplace. OBIO advances this goal through advocacy,
promotion and strategic leadership and via collaborative partnerships
with industry, academia, patients and government. For more information,
visit www.obio.ca
and follow OBIO on Twitter @OBIOscience.

Contacts

Gail Garland
President and CEO
gailgarland@obio.ca
416-848-6839
ext. 101

Christina Yeh
Program Manager, Pre-CAAP
christinayeh@obio.ca
416-848-6839
ext. 107